Search Videos and More

Showing 1 - 12 of 17 results

Previous| 1 | 2 |Next


San Antonio Breast Cancer Symposium (SABCS): December 2021 Symposium

San Antonio Breast Cancer Symposium (SABCS): December 2021

Dana-Farber Cancer Institute faculty highlights from the 2021 San Antonio Breast Cancer Symposium.
Inadequate SARS-COV-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study Video

Inadequate SARS-COV-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study

Dana-Farber Cancer Institute's Nikhil C. Munshi, MD, details study looking at COVID-19 vaccine effectiveness in patients with multiple myeloma. Research presented at ASH21.
Blood Cancer Research: Clinical Trial Helps Younger Patient Video

Blood Cancer Research: Clinical Trial Helps Younger Patient

A patient shares her journey getting diagnosed with chronic lymphocytic leukemia in her 30's. Dana-Farber Cancer Institute's Matthew Davids, MD, MMSc, enrolled her on a clinical trial and details the results of that study. The research is now getting presented at ASH21.
ASH 2021 Highlights - CME News

ASH 2021 Highlights - CME

Register for 2021 ASH Highlights CME
New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma Video

New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma

Dana-Farber Cancer Institute research shows elevated rates of a blood cancer precursor condition in groups at high risk for multiple myeloma.
American Society of Hematology (ASH) Annual Meeting News

American Society of Hematology (ASH) Annual Meeting

As leaders in blood and blood cancer research, physicians and scientists from Dana-Farber Cancer Institute shared advances and insights at the 63rd Annual Meeting of the American Society of Hematology (ASH) on December 11–14, 2021 in Atlanta, Georgia
New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma News

New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma

The first results from the largest screening study yet conducted in the United States of individuals at above-average risk for the blood cancer multiple myeloma have revealed higher rates of a myeloma precursor condition in older adults who are Black or who have a close family member with a current or past blood cancer.
Adjuvant Palbociclib in HR+/HER2 Early Breast Cancer - Final results from PALLAS Trial Video

Adjuvant Palbociclib in HR+/HER2 Early Breast Cancer - Final results from PALLAS Trial

Dana-Farber's Erica Mayer, MD, MPH discusses the final analysis of the International Phase 3 PALLAS clinical trial presented at the 2021 San Antonio Breast Cancer Symposium.
GS2-05 Update on the Combined TEXT and SOFT Trials Video

GS2-05 Update on the Combined TEXT and SOFT Trials

Dana-Farber's Meredith Regan, ScD presented an update on the SOFT/TEXT clinical trials at the 2021 San Antonio Breast Cancer Symposium.
Dana-Farber Researchers Present Findings at San Antonio Breast Cancer Symposium News

Dana-Farber Researchers Present Findings at San Antonio Breast Cancer Symposium

Researchers from Dana-Farber Cancer Institute will present more than 30 research studies at the 44th annual San Antonio Breast Cancer Symposium on December 7-10th.
ASH 2021 Featured Oral Presentations Document

ASH 2021 Featured Oral Presentations

The Annual Meeting of the American Society of Hematology (ASH) will take place December 11-14th. To keep-up with latest advances, the live schedule of oral presentations by Dana-Farber faculty is attached for your convenience.
Dana-Farber at ASCO News

Dana-Farber at ASCO

The Annual Meeting of the American Society of Clinical Oncology (ASCO) will take place virtually June 4-8th.

Showing 1 - 12 of 17 results

Previous| 1 | 2 |Next